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NeurodegenerationFor decades, studies have been focusing on the neuronal abnormalities that accompany neurodegenerative dis-
orders. Yet, glial cells are emerging as important players in numerous neurological diseases. Astrocytes, the
main type of glia in the central nervous system , form extensive networks that physically and functionally con-
nect neuronal synapses with cerebral blood vessels. Normal brain functioning strictly depends on highly special-
ized cellular cross-talk between these different partners to which Ca2+, as a signaling ion, largely contributes.
Altered intracellular Ca2+ levels are associated with neurodegenerative disorders and play a crucial role in the
glial responses to injury. Intracellular Ca2+ increases in single astrocytes can be propagated toward neighboring
cells as intercellular Ca2+ waves, thereby recruiting a larger group of cells. Intercellular Ca2+ wave propagation
depends on two, parallel, connexin (Cx) channel-based mechanisms: i) the diffusion of inositol 1,4,5-trisphos-
phate through gap junction channels that directly connect the cytoplasm of neighboring cells, and ii) the release
of paracrinemessengers such as glutamate and ATP through hemichannels (‘half of a gap junction channel’). This
review gives an overview of the current knowledge on Cx-mediated Ca2+ communication among astrocytes as
well as between astrocytes and other brain cell types in physiology and pathology, with a focus on the processes
of neurodegeneration and reactive gliosis. Research on Cx-mediated astroglial Ca2+ communication may ulti-
mately shed light on the development of targeted therapies for neurodegenerative disorders in which astrocytes
participate. This article is part of a Special Issue entitled: Calcium signaling in health and disease. Guest Editors:
Geert Bultynck, Jacques Haiech, Claus W. Heizmann, Joachim Krebs, and Marc Moreau.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
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occurs between neurons, astrocytes, oligodendrocytes, activated mi-
croglia, vascular cells and ependymal cells [2] and is in large partQP4, aquaporin 4; APP, amyloid precursor protein; BAPTA, 1,2-bis(2-aminophenoxy)eth-
tion; [Ca2+]i, cytoplasmic Ca2+ concentration; cADPR, cyclic adenosine diphosphoribose;
pression; Cx, connexin; EAE, experimental autoimmune encephalomyelitis; ER, endoplas-
intercellular coupling; GPCR, G-protein-coupled receptor; HC, hemichannel; IICR, inositol
; IP3, inositol 1,4,5-trisphosphate; IP3R, inositol 1,4,5-trisphosphate receptor; [K+]e, extra-
ride; MAM,mitochondria-associated endoplasmic reticulummembrane; MCU, mitochon-
denine dinucleotide; NCX, Na+/Ca2+ exchanger; NFAT, nuclear factor of activated T-cells;
ceptor; NO, nitric oxide; Panx, Pannexin; PLC, phospholipase C; PGE2, prostaglandin E2; PS,
active oxygen species; RyR, ryanodine receptor; SMC, smooth muscle cell; SOCE, store-
al channel; VDAC, voltage-dependent anion channel
itors: Geert Bultynck, Jacques Haiech, ClausW. Heizmann, JoachimKrebs, andMarcMoreau.
rsity, De Pintelaan 185 (Block B, 3rd floor), B-9000 Ghent, Belgium. Tel.: +32 9 332 39
aanderen), Belgium.
2212 M. De Bock et al. / Biochimica et Biophysica Acta 1843 (2014) 2211–2232mediated by paracrine signaling, involving the release, diffusion and in-
teraction of a messenger molecule with its receptor. Additionally, more
direct signaling is possible by the exchange of ions and low molecular
weight (MW) molecules (b1.5 kDa) via gap junctions (GJs) that cluster
in plaques and directly connect the cytoplasm of neighboring cells. GJs
are formed by the docking of two hemichannels (HCs). The plasma
membrane normally also contains HCs not incorporated into GJs
which are sometimes referred to as unapposed HCs. TheseHCs are com-
monly closed butmay be activated in response to various stimuli, there-
by opening a pore that allows ionic and molecular exchange between
the intra- and extracellular environment. Opening of unapposed HCs
is a potential pathway for the diffusive release of messenger molecules
like ATP and glutamate and may therefore contribute to paracrine sig-
naling [3]. GJs and HCs are composed of connexin (Cx) subunits ar-
ranged in a, respectively dodecameric or hexameric, configuration. Cxs
are tetraspan membrane proteins of which 21 human species have
been identified and named according to their MW. Pannexins (Panxs)
are another family of channel-forming proteins that have topological
similarity to Cx hemichannels. Currently, three human Panxs (Panx1–
3) have been identified. Both Cx43 and Panx1 are predominant in the
CNS (Table 1) [4–8].
Normal brain functioning strictly depends on highly specialized cel-
lular cross-talk to which calcium ions (Ca2+) largely contribute as a sec-
ond messenger. In the brain, Cx/Panx channels crucially contribute to
the cell-to-cell propagation of increases in the cytoplasmic free Ca2+
concentration ([Ca2+]i), known as intercellular Ca2+ waves (ICWs)
[9–11]. Neuronal communication primarily relies on action potential fir-
ing whereby [Ca2+]i changes have a critical role in regulating neuro-
transmitter release, synaptic plasticity and gene expression [12–14].
For electrically non-excitable cells such as glia and vascular endothelial
cells, Ca2+ signals are the major fast (on a second time scale) system
available for intra- as well as intercellular signaling. ICWs typically
emerge in glial networks [11,15] as has been demonstrated in vivo
[16–19], bringing up the question whether these ICWs play an active
role in normal brain functioning and information processing, particularly
at the level of synaptic signaling and regulation of blood supply. In addi-
tion, a wide diversity of pathologies (e.g. brain ischemia [20],
Alzheimer's disease (AD) [21,22], CNS traumatic injury [23,24] and epi-
lepsy [25,26]) has been associatedwith abnormal intercellular Ca2+ sig-
naling, which is linked to inflammatory conditions and unwarranted cell
death, supporting a pathological function for ICWs. In this review, we
discuss the currently available evidence that describes Ca2+ signaling
in the brain, focusing on intra- and intercellular glial Ca2+ signaling
and the contribution of Cx channels, both in physiology and pathology.
2. The neuro-glio-vascular unit
The term ‘neurovascular unit’ originally emerged as a concept to
widen the scope of possibilities for therapeutic interventions in stroke
(Report of the Stroke Progress Research Group, 2002, www.ninds.nih.
gov) andhas been instrumental in scalingdown the classical neurocentric
view in favor of a more integrated approach by including vascular and
blood targets. We indulge in denoting this unit as the ‘neuro-glio-Table 1
Main connexin and pannexin species expressed in the neurogliovascular unit.
Connexin Pannexin
Astrocyte Cx26, Cx30, Cx43 Panx1, Panx2a
Microglia Cx32, Cx36, Cx43b Panx1
Oligodendrocyte Cx29, Cx32, Cx47 Panx1, Panx2
Neuron Cx30.2, Cx31.1, Cx36, Cx40, Cx45 Panx1, Panx2
Endothelial cell Cx37, Cx40, Cx43 ND
Pericyte Cx37, Cx40, Cx43 ND
a De novo expression in reactive hippocampal astrocytes subjected to ischemia/
reperfusion injury.
b Expressed in activated microglia, not in resting microglia.vascular unit’ (NGVU) to underscore the importance of glial cells as cen-
tral players linking neurons to the cerebral vasculature. TheNGVU is com-
posed of neurons, astrocytes, microglial cells, endothelial cells, pericytes,
smoothmuscle cells (SMCs) and circulating blood cells [27] (Fig. 1). Func-
tionally, these cells interact to control synaptic communication, blood–
brain barrier (BBB) function, local blood supply, neuronal development
and surveillance/immune function [28].
Astrocytes are centrally positioned within the NGVU, where they
form extensive networks that physically and functionally connect neu-
ronal synapses with cerebral vessels [2]. At one end, astrocytes send
their processes to neuronal synapses, where they join pre- and postsyn-
aptic structures, altogether forming a ‘tripartite synapse’. A single ro-
dent astrocyte may contact an estimated 140,000 synapses while in
the human brain, astrocytes are hypothesized to support and modulate
the function of roughly two million synapses [29,30]. By surrounding
the synaptic cleft, astrocytes sense neuronal signaling activities and
modulate them by secreting gliotransmitters like ATP, glutamate,
D-serine and adenosine [31–36]. At the other end, astrocytes project
‘endfeet’ onto brain capillary endothelial cells and pericytes, thereby
enwrapping 98% of the vascular surface area. At the synaptic as well as
vascular contact points, astrocytes are additionally equipped with a
large repertoire of neurotransmitter receptors [37] that sense synaptic,
neurometabolic and vascular activities. The dual contact with neurons
and cerebral vessels thus provides astrocytes with the unique architec-
tural advantage for sensing neuronal activity, integrating electrochemi-
cal information and exchanging this information with the vasculature,
for example, by releasing vasoactive substances such as nitric oxide
(NO), prostacyclins, epoxyeicosatrienoic acids, glutamate, adenosine
and ATP [38–40]. As such, the NGVU performs a homeostatic control
over the neuronal milieu, which is required for proper functioning of
neurons and their synapses.3. Connexin signaling and glial network communication
Twelve Cxs and two Panxs have been identified in the various CNS
cell types (Table 1). Each cell type expresses a unique combination of
Cx species that typically depends on the brain region and on the
developmental stage, with Cx43 being most ubiquitously expressed
[6–8,41–43]. It is predominant in astrocytes, activated microglia, devel-
oping neurons, SMCs, endothelial cells and pericytes. Cx-mediated in-
tercellular communication, being a typical feature of glial cells, is
thought to play an important role in signal transmission at the NGVU,
primarily via the formation of glial networks [44].
Astroglial cells prominently express Cxs and through extensive
gap junctional coupling they establish astrocytic networks that sup-
port long-range communication and transport [44]. Importantly,
interastroglial coupling is not uniform but endowed with anatomical
or functional specificity, and is subject to modulation [45,46]. Cx43
and Cx30 are the main Cx species expressed in astrocytes and both
contribute to GJ-mediated intercellular coupling (GJIC) between
these cells [47–52]. Cx43 and Cx30 are primarily expressed in astro-
cytic processes that surround the synaptic cleft, but are also enriched
in astrocytic endfeet. As GJs, these Cxs support intercellular traffick-
ing of ions and small signaling molecules through perivascular and
perisynaptic astroglial networks. Recent data obtained from trans-
genic mice with a targeted deletion of Cx26 in neuronal and glial
cells, provided unequivocal evidence for the additional presence of
Cx26 in astrocytic GJ plaques as well as for heterotypic plaques
formed between astrocytes and oligodendrocytes [53]. Other Cxs
(Cx40 and Cx45) have been detected in astrocytes, but are expressed
at low levels [54,55]. The pattern of Cx expression in astrocytes is
subject to alterations; e.g., Cx30 and Cx43 are upregulated in the
presence of synaptically active neurons [51,56] and astrocyte-
specific Cx43 knock-out (KO) is associated with a compensatory in-
crease in Cx30 expression [57]. Under pathological conditions, Cx
Fig. 1. Schematic diagramof the neurogliovascular unit. Astrocytes send projections towards the synapse,where they form the tripartite synapse togetherwith pre-and postsynaptic nerve
terminals. At the other end, astrocyte endfeet enwrap the vascular wall from the capillary to the arteriolar level. It this way, neurons can influence the endothelium, using the astrocytes as
intermediate players.
2213M. De Bock et al. / Biochimica et Biophysica Acta 1843 (2014) 2211–2232expression may additionally experience marked changes (see
Section 5).
Several global and conditional Cx KO mice for the glial Cxs (Cx43,
Cx30 and Cx26) are available and, as a consequence of the previously
mentioned compensatory changes in the expression levels of other
Cxs, KO mice deficient for multiple glial Cxs have been generated as
well [45]. Targeted astrocytic ablation of Cx43 on a global Cx30KOback-
ground rendersmice that are largely devoid of astrocytic GJIC. The diffu-
sion of glucose metabolites through the astrocytic network was
abolished in hippocampal slices from these double KOmice [49]. Astro-
cytic networks exert homeostatic control over the composition of the
extracellular environment, thereby influencing neuronal function and
survival. Astrocytic GJIC is crucial for the supply and delivery of energy
molecules and for the removal and spatial buffering of extracellular
K+ and glutamate [2,52]. Increased neuronal activity augments astro-
cytic GJIC [49,58] and induces vasodilation of upstream pial arterioles.
While inmost perfusion beds, upstream signaling from capillaries to ar-
terioles ismediated by the communication of electrical signals via endo-
thelial GJs, there seems to be an alternative pathway in the brain
consisting of the propagation of Ca2+ signals over astrocytic endfeet
that strongly express Cx43 [59]. Work with Cx30/Cx43 double KO ani-
mals has additionally provided evidence that these Cxs are necessary
for normal BBB integrity and function [48]. The evidence above strongly
suggests that energy delivery, clearing and signaling functions of
astroglial Cx channels are adapted to the level of neuronal activity. At
the neuronal and vascular contact points, transport and signaling inter-
actions with the glial network are mainly governed by mechanismsother than GJs [50,60] although direct signaling through neuron–glial
or endothelial–glial GJs has been reported in cell culture systems
[61–64]. By means of immunolabeling techniques or functional assays,
GJs between astrocytes and neurons have been detected in brain slices
[65–67]. GJs between astrocytes and endothelial cells have been de-
scribed in cell culture models [68] but they are normally not present
at the healthy astrocyte–endothelial interface, presumably because of
the presence of a continuous basal membrane. However, this does not
exclude the possibility that heterocellular astrocyte–endothelial GJs
can form under pathological conditions.
The participation of GJs in brain functioning has been abundantly
reviewed but evidence for contribution of astrocytic HCs has only
been accumulating over the past 10 years [69,70]. Before being incorpo-
rated into GJs, HCs form a bidirectional diffusion pathway for ions, small
signaling molecules and energy substrates [3,69,71]. In this respect,
Cx43 HCs have been demonstrated, mostly under in vitro conditions,
to function as a release pathway for molecules such as ATP, glutamate,
prostaglandin E2 (PGE2), nicotinamide adenine dinucleotide (NAD+)
and inositol 1,4,5-trisphosphate (IP3) [72–77]. Cx43 HC opening has
also been proposed to act as a pathway for the uptake of energy mole-
cules in astrocytes in response to pro-inflammatory cytokines [78].
However, the biological significance of HCs is still a matter of debate
as it is hard to understand how a poorly selective plasma membrane
channel, with a conductance about twice the conductance of the corre-
sponding GJ channel [79,80], can contribute to the normal functioning
of a cell [81]. It was therefore hypothesized that HCs remain closed
under most conditions to prevent leakage of metabolites and nutrients
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and cell death. Under resting conditions, Cx43 HCs exhibit a low open
probability in cultured cells [79,82] that can be increased by exposure
to various stimuli such asmechanical stimulation, changes in phosphor-
ylation status [83], ischemic conditions [84], pro-inflammatory cyto-
kines [78], oxidative stress [85], and an increase in [Ca2+]i [86] or
decrease in extracellular Ca2+ concentration ([Ca2+]e) [87]. Although
most of these stimuli are associated with cellular stress, HC function
has been associatedwith various aspects of the cellular life cycle, includ-
ing cell proliferation, as well as with the normal functioning of various
cell types [88]. Their involvement under normal non-pathological con-
ditions is now supported by the observation that [Ca2+]i changes, in
the physiological (submicromolar) range, trigger HC opening [86,89].
HC activity has also been recorded in cells exposed to endogenous li-
gands associated with cell proliferation and differentiation [83,90,91].
Nerve growth factor stimulated neurite outgrowth in PC12 cells was
for instance mediated by HCs through ATP release [90]. Recently,
Stehberg and co-workers pinpointed a contribution of astroglial Cx43
HCs in the basolateral amygdala to the consodilation of fear memory
[92], suggesting a role of these channels in gliotransmitter release. Of
note, functional Panx1 HCs have also been reported in astrocytes, but
their role as gliotransmitter release channels has been less characterized
and they do not form GJs between cultured astrocytes [93–95]. Hence,
these channels are further referred to as Panx channels instead of
Panx HCs [96].
Besides forming channels, Cxs also exert non-channel signaling
functions [97,98]. Growing evidence suggests that Cx proteins directly
control gene expression. Cx gene transfection is indeed known to affect
the expression of genes encoding for growth-, differentiation- and cell
death-modulating proteins [98]. The up- or down-regulation of various
geneswith diverse functions in the brain of Cx43-nullmice indicate that
Cxs regulate multiple cellular processes [99,100]. Irrespective of their
channel-forming capacity, Cxs modulate P2Y receptor signaling [101,
102] and cytoskeletal proteins in astrocytes [103]. Recently, Cxs were
found to be crucial for glial-guided neuronal migration without acting
in the classical channel-mediated manner [104,105]. Instead, Cx26 and
Cx43 GJs, expressed at the contact points between radial fibers and mi-
grating neurons, provided dynamic adhesive contacts that interact with
the internal cytoskeleton to enable leading process stabilization along
radialfibers aswell as the subsequent translocation of the nucleus [104].
4. Ca2+ signaling in the healthy brain
4.1. General concepts of intra- and intercellular Ca2+ signaling
[Ca2+]i is regulated through a strongly organized interplay between
Ca2+ entry from the extracellular space, Ca2+ release from intracellular
storage sites, and Ca2+ extrusion out of the cells or its sequestration
back into the stores. Most cytoplasmic Ca2+ is furthermore bound by
Ca2+ buffering proteins such as parvalbumin, calretinin and calbindin
[106]. As a result, [Ca2+]i in resting brain cells varies between 80 nM
and 100 nM [21,107]. At high cytosolic levels, Ca2+ ions have a deleteri-
ous action; they cause aggregation of proteins and nucleic acids, affect
the integrity of lipid membranes and initiate the precipitation of phos-
phates, and are thus incompatible with life [108]. Therefore, all living
cells keep [Ca2+]i at low nanomolar levels, creating a steep concentra-
tion gradient between the extracellular environment (~1 mM
[109–111]), the cytoplasm and the Ca2+ store content. Free cytoplasmic
Ca2+ represents only a small part of the total cellular Ca2+ as most of
the intracellular Ca2+ is sequestered in intracellular stores to prevent
the toxic effects of a high [Ca2+]i. The endoplasmic reticulum (ER) is
considered the predominant Ca2+ store as it contains approximately
70% of the cell's total Ca2+ reserve, corresponding to Ca2+ concentra-
tions up to 0.5 mM [112–114]. Additionally, mitochondria play an im-
portant role in the Ca2+ household of cells [115]. Transport across the
plasma membrane and membranes of the intracellular compartmentsis governed by a family of Ca2+ channels and transporters that are
based on the diffusion of Ca2+ down its concentration gradient (passive
downhill), causing an increase in [Ca2+]i. The clearance of cytosolic
Ca2+ depends on different energy-dependent transport mechanisms
that act against the concentration gradient (active uphill) (Table 2)
[116].
Variations in [Ca2+]i control a multitude of biological processes over
a wide dynamic range including cell proliferation, differentiation, neu-
rotransmitter release, secretion, synaptic plasticity, gene expression,
immune responses, muscle contraction, endothelial permeability, apo-
ptosis and many others [106]. To ensure specificity, Ca2+ signals are
highly organized in time and space [10]. Rapid and highly localized
Ca2+ spikes may co-occur or evolve into slower global [Ca2+]i changes
that are either transient, repetitive or sustained. Neuronal [Ca2+]i rises
mainly rely on Ca2+ entry via voltage- and receptor-operated plasma
membrane channels, evoking highly localized and precisely timed
[Ca2+]i increases that ensure a fast, focal and timed neurotransmitter
release from synaptic terminals [12]. In contrast, macroglial (astrocytes
and oligodendrocytes) aswell asmicroglial Ca2+ signalingmechanisms
mostly rely on Ca2+ release from the ER. This creates a longer-lasting
[Ca2+]i elevation that is hypothesized to control a slower, and perhaps
more sustained release of gliotransmitters [15]. The activation of
store-operated Ca2+ entry (SOCE) following the depletion of the ER
Ca2+ store, is equally important for shaping glial Ca2+ signals [117]. It
gives rise to a sustained Ca2+ signal which may significantly outlast
the periods of ER Ca2+ release induced by metabotropic receptor stim-
ulation [17]. The key molecular players of SOCE are the stromal interac-
tion molecules, which sense the luminal ER Ca2+ levels and control the
opening of plasma membrane Orai channels [118,119]. In addition, Tran-
sient Receptor Potential (TRP) channels of the canonical family (TRPC)
may contribute to SOCE [120], but this remains controversial [121].
The ER is the largest and most controlled intracellular Ca2+ store
[122]. Generally, Ca2+ release from the ER is mediated by two families
of receptor channels, IP3 receptors (IP3Rs) and ryanodine receptors
(RyRs), which are both represented by three isoforms (IP3R1–3 and
RyR1–3) [123–126]. Ca2+ itself is an activator of RyR channels and a po-
tent regulator of IP3-induced Ca2+ release; Ca2+ thus provides a regen-
erative autocatalytic mechanism which is referred to as Ca2+-induced
Ca2+ release [127]. The primary activation mechanism of IP3Rs is IP3
binding. IP3 is generated by phospolipase C (PLC), which is linked to a
multitude of plasmalemmalmetabotropic receptors. There are 13differ-
ent PLC isoforms, which are divided into six different classes (PLCβ,
PLCγ, PLCδ, PLCε, PLCζ and PLCη) based on their structure. These PLC
proteins can be activated via differentmechanisms including the stimu-
lation of G-protein-coupled receptors (GPCRs), receptor and non-
receptor tyrosine kinases, the activation of the small G-protein Ras, or
by an increase in [Ca2+]i [128]. PLC catalyzes the cleavage of
phosphoinositol-4,5-bisphosphate into diacylglycerol and IP3. The latter
diffuses inside the cell and binds its receptors located on the ER surface,
resulting in IP3-induced Ca2+ release (IICR) from the ER [116]. Astro-
cytes are equipped with a large repertoire of neurotransmitter recep-
tors, many of which couple to the activation of PLC, production of IP3
and subsequent release of Ca2+ from internal stores [37,129]. At low
levels of stimulation, single IP3R channels open resulting in brief and lo-
calized Ca2+ blips, but usually, coordinated opening of clusters of IP3Rs
takes place, giving rise to Ca2+ puffs. Under certain conditions, these lo-
calized eventsmay expand and recruit nearby ER Ca2+ channels to gen-
erate an intracellular Ca2+ wave sweeping over the cytoplasm thereby
globalizing the Ca2+ response within the cell [130]. The spatio-
temporal organization of Ca2+ signals thus tightly depends on the rear-
rangement of the Ca2+ channels on the ER surface, as well as their close
contact with other Ca2+-sequestering organelles such as mitochondria.
It becomes increasingly recognized that mitochondria play an im-
portant role in shaping the Ca2+ signals [115,131]. Consequent to pro-
ton extrusion by the electron transfer chain, required for ATP
synthesis, mitochondria have an internally negative electrical potential
Table 2
Mechanisms of Ca2+ transport between cytoplasm and extracellular environment or intracellular stores.
Passive downhill Transport mode Remarks
EC to cytoplasm –Voltage-operated channel
–Receptor-operated channel
–Store-operated channel
–Second messenger-operated channel
–Non-selective channel
ER to cytoplasm –IP3R
–RyR
–ER leak channelsa
between cytoplasm and mitochondria –MCU
–VDAC
–PTP
MCU is a highly selective Ca2+ channel across the IMM while VDAC is the major regulator
across the OMM
PTP opening is associated with pathological conditions and results in Ca2+ transport from
mitochondria to the cytoplasm
Golgi to cytoplasm IP3R
lysosomes and endosomes to cytoplasm TPC
Active uphill Transport mode Remarks
cytoplasm to EC PMCA
cytoplasm to ER SERCA
cytoplasm to Golgi –SPCA
–SERCA
Secondary active uphill Transport mode Remarks
plasma membrane NCX The energy of the Na+ or H+ gradient is used to extrude Ca2+ from the cell or from the
mitochondria, however, it can work in reverse mode depending on the transmembrane
Na+, H+ or Ca2+ gradients and membrane depolarization
mitochondrial membrane –NCX
–H+/Ca2+ antiporter
This list summarizes the most important Ca2+-permeable channels and pumps responsible for the Ca2+ transport between the compartments. Additional less-known mechanisms are
reported to contribute but are not mentioned in the scheme.
(EC, extracellular environment; IMM, innermitochondrial membrane; MCU, mitochondrial Ca2+ uniporter; NCX, Na+/Ca2+ exchanger; OMM, outer mitochondrial membrane; PMCA, plas-
ma membrane Ca2+ ATPase; PTP, permeability transition pore; SERCA, sarco-endoplasmic reticulum Ca2+ ATPase; SPCA, secretory pathway Ca2+ ATPase; TPC, two-pore channels; VDAC,
voltage-dependent anion channel).
a ER leak channels remain unidentified up to date, but IP3R, RyR, TRP and Panx channels have been suggested to contribute to the Ca2+ leak.
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Ca2+ uptake is mediated by the voltage-dependent anion channel
(VDAC) located at the outer mitochondrial membrane and the mito-
chondrial Ca2+ uniporter (MCU) which is situated in the inner mito-
chondrial membrane [132–136]. Mitochondria accumulate Ca2+ more
effectively when they are close to sites of high Ca2+ concentration
[137,138]. They are physically and functionally connected to the ER,
separated by a distance in the range of 10–30 nm [139,140] that facili-
tates the uptake of Ca2+ released by the ER [141]. Contact sites between
the two organelles are known as mitochondria-associated ER mem-
branes or MAMs [142,143]. These are intracellular lipid raft-like struc-
tures intimately involved in cholesterol and phospholipid metabolism,
and in Ca2+ homeostasis by providing direct transfer of ER-derived
Ca2+ to the mitochondria [144–149]. Approximately 75 proteins have
been reported to be associated with the MAMs [150]. Mitofusin 2 pro-
teins are important for the tethering of the two organelles [151,152]
and other proteins such as phosphofurin acidic cluster sorting protein
2, are reported to stabilize and regulate the interaction [153]. An inter-
action between the IP3R1 and VDAC1 via the chaperone ‘glucose regu-
lated protein 75’ favors Ca2+ transfer [151]. Upon IICR, local
microdomainswith Ca2+ concentrations exceeding ~10 μM(‘hotspots’)
are created in the vicinity of mitochondria [137,141], favoring mito-
chondrial Ca2+ entry via the MCU that has an intrinsic low Ca2+ affinity
(EC50 is 10–20 μM) [138,154]. A major role of mitochondrial Ca2+ entry
and consequent increase of matrix [Ca2+] consists in the stimulation of
ATP production by activating Ca2+-sensitive dehydrogenases of the Krebs
cycle, regulating the activity of the ATP synthase and promoting the supply
of oxidizable substrates [131,155–157]. Once the cytosolic Ca2+ has
returned to its resting level, mitochondrial Na+/Ca2+ exchangers (NCX)
or H+/Ca2+ antiporters transport Ca2+ from the mitochondrial matrix
into the cytoplasm, from where it is either recycled to the ER or removed
fromthecell [158,159].MAMs thusemerge as signalinghubs controlingox-
idative cell energymetabolism and alterations at theMAMs are implicatedin a wide spectrum of diseases, including ischemia and neurodegenerative
disorders (see Section 5, and [148,160]).
Ca2+ waves are not always restricted to the cytosol of a single cell,
but can cross the cell boundaries to form an ICW (Fig. 2). GJs offer the
most direct route for ICW propagation by allowing the transfer of
Ca2+ and IP3. Ca2+ diffusion in the cytoplasm is slow (diffusion constant
in the order of 13 to 65 μm2/s) due to the presence of slowly mobile
Ca2+ binding proteins [161,162]. In contrast, the diffusion of IP3 (MW
420 Da) is faster (diffusion constant ~283 μm2/s) and GJs are more per-
meable to IP3 than to Ca2+ (100-fold difference) [161,163]. Thus, Ca2+
can pass through GJs, but it reaches the adjacent cell with some delay
compared to IP3. IP3 therefore stands out as the primary Ca2+ signaling
molecule passing via GJs [164]. Notably, GJs display selective permeabil-
ity toward IP3 depending on their Cx composition. Niessen and col-
leagues demonstrated that microinjection of IP3 into HeLaCx32 cells
triggered ICWs that were 3- to 4-fold more widespread than in
HeLaCx26 cells and 2.5-fold larger than in HeLaCx43 cells [165]. Cyclic
adenosine diphosphoribose (cADPR; MW 541 Da) is another GJ-
permeable intercellular signaling molecule that triggers ICWs upon in-
jection in astrocytes, but Ca2+ wave propagation is slower as compared
to IP3-based ICWs [166]. cADPR is synthesized from NAD+ by the ADP-
ribosyl cyclase CD38, which is located on the cell surface and intracellu-
lar membranes. cADPR functions as a Ca2+ messenger by modulating
the Ca2+ sensitivity of RyRs and appears to play an important role in
Ca2+ signaling in the CNS, including in glial cells [167,168]. Apart from
GJIC, non-junctional paracrine signaling also contributes to thepropaga-
tion of ICWs (Fig. 2) [9–11]. The extracellular messengers involved are
in most cases ATP or glutamate [169–173], but others such as NO
[174] andNAD+ [175] have also been suggested. Release of ATP and glu-
tamate has been documented to occur via exocytosis or diffusion
through Cx HCs, Panx channels, or P2X7 receptor channels [72,73,94,
171,176–180]. The downstream effect of these messengers involves
the GPCR-PLC-IP3 signaling axis or Ca2+ entry via plasma membrane
Fig. 2.Mechanisms underlying intercellular Ca2+ signaling. The activation of plasma membrane GPCRs results in the PLC-mediated synthesis of IP3 and subsequent IICR from the ER. Mi-
tochondrial Ca2+ uptake prevents Ca2+ from reaching deleterious levels in the cytoplasm. The intracellular Ca2+ signal can propagate to neighboring cells via two routes, a direct one
involving GJs, with IP3 as the primary coordinating messenger, and an indirect one that is mediated by the release of paracrine messengers. Here, ATP and glutamate are the prototypical
paracrine molecules released into the extracellular environment via multiple mechanisms including HCs, a vesicular pathway or channels such as the P2X7 receptor. They diffuse in the
extracellular space and activate their corresponding GPCRs or channels on neighboring cells. Regenerative mechanisms include the Ca2+-dependent activation of PLCδ or stimulation of
paracrine releasemechanisms. (CxHC, connexin hemichannel; ER, endoplasmic reticulum; GJ, gap junction; GqPCR, G-protein coupled receptor; IICR, inositol 1,4,5-trisphosphate-induced
Ca2+ release; PIP2, phosphatidylinositol 4,5-bisphosphate; PLC, phospholipase C; IP3, inositol 1,4,5-trisphosphate; IP3R, inositol 1,4,5-trisphosphate receptor).
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converted extracellularly into cADPR. The plasma membrane CD38 en-
zyme subsequently transports cADPR back into the cell [76]. In most
cases, ICW propagation is sustained by both the GJ and paracrine path-
way, supported by regenerative steps which result in more extensive
ICWs [9]. GJ-mediated regenerative processes rely on Ca2+-triggered
regeneration of IP3 via the activation of PLCδ [163]. Paracrinemessenger
regeneration is supported by the Ca2+-dependence of vesicular but also
HC release mechanisms [86,181–183].
4.2. Intercellular Ca2+ signaling in the NGVU
Although several tissues and organs display ICWs or inmore general
terms ‘intercellular Ca2+ signaling’ (as the typical concentric wave as-
pect is not always present), the case is especially strong for the brain,
where Ca2+ is a basic signal for glial network communication (Fig. 3).
Evidence demonstrating Ca2+ signals propagating over tens to hun-
dreds of astrocytes in cell culture started to appear more than
20 years ago [169–171,179,184–187]. Although the true function of
inter-astrocyte Ca2+ signals is still unclear, the central position of astro-
cytes in theNGVU,making contactswith neurons, vascular cells andmi-
croglia (Fig. 3) has been a major factor in driving a continued interest
and experimental exploration. There is now evidence for glial ICWs in
more complex ex vivo preparations such as hippocampal and cortical
slices [50,174,188–191]. For example, Weissman and colleagues dem-
onstrated ICWs in radial glia that postnatally transform into astrocytes
in the proliferative cortical ventricular zone of the developing neocortex
[188]. The latter require Cx HCs, P2Y1 receptors and IICR, and are pro-
posed to regulate cortical neuron proliferation. More recently, advances
made in the field of two-photon microscopy have enabled visualization
of astrocyte Ca2+ dynamics (not necessarilywaves) in vivo (Table 3 and
[16,17,21,192–194]), either arising spontaneously [16,17] or in re-
sponse to somatosensory [195] or visual stimulation [194]. Spontane-
ously occurring wave-like Ca2+ signal propagation has been observed
in glial cells of the hippocampus [18], the neocortex [17], the cerebellum[16,19] and the retina [196] (Table 3). Local application of bicuculline to
increase neuronal activity by suppressing GABA-signaling triggers as-
trocytic ICW activity in vivo [193] but evidence supporting astrocytic
ICW generation in response to physiological levels of stimulation is
still lacking.
Astrocytic ICWs have been reported to spread at a uniform speed of
5–20 μm/s, which is several orders of magnitude slower than the prop-
agation of neuronal electrical signals [16,188]. In vivo, ICWs propagate
over astrocyte networks with even lower velocities in the order of
8–10 μm/s [197]. The relative contribution of paracrine/purinergic signal-
ing and GJIC to ICWs is likely to depend on brain region-specific factors
[198] and on the nature of the applied trigger [188]. In acutely isolated
retina, mechanical stimulation evokes ICWs among astrocytes which
depend on GJIC, while the propagation from astrocytes to Müller cells
involves purinergic, paracrine signaling [199]. In the corpus callosum
and hippocampus, glial ICWs were blocked by purinergic receptor an-
tagonists, but were insensitive to GJ blockers and the deletion of Cx43
or Cx30 expression using conditional Cx43(fl/fl):GFAP-cre mice and
Cx30−/− KO mice [198,200]. In contrast, in the neocortex, glial ICWs
depend on functional GJs as well as ATP release [198]. There is cross-
talk between the gap junctional and the paracrine pathways of ICW
propagation: deletion of Cx43 in spinal cord astrocytes leads to an in-
crease in paracrine, purinergic Ca2+ signaling by a switch in the P2Y re-
ceptor subtype, resulting in increased responses to ATP or uridine 5′-
triphosphate [102]. Additionally, the cytoplasmic C-terminal domain
of Cx43 modulates the activity of the P2Y1 receptor in astrocytes via a
protein–protein interaction between Cx43 and the P2Y1 receptor, in-
volving the Cx43 C-terminal SH3-binding domain [101].
Astrocytic [Ca2+]i changes modulate synaptic transmission in
in vitro astrocyte–neuron co-culture systems, the intact retina and hip-
pocampal slices [61,201–203]. Astrocytes remove and recycle K+ ions
and neurotransmitters from the synaptic cleft [204], but also respond
to neurotransmitters bymeans of a large family of membrane receptors
[37,192,205]. The ensuing signaling, often involving [Ca2+]i changes,
triggers the release of gliotransmitters such as glutamate, D-serine,
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synaptic neurotransmitter release, excitatory postsynaptic firing and
extrasynaptic neuronal activity [207,210,211], neuronal circuit plastici-
ty [212], and neuronal survival (see Section 5). The source of cytosolic
Ca2+ that mediates gliotransmitter release is dual; it is predominatelyFig. 3. Ca2+ signaling at theNGVU. At the level of the synapse, astrocytes perform three key func
and K+ ions, from the synaptic cleft, astrocytes protect neurons from excitotoxicity. Additionally
an increase in [Ca2+]i. Subsequently, astrocytes release so-called gliotransmitters via which the
propagated to neighboring astrocytes via either the gap junctional or the paracrine route whic
synaptic activity will additionally propagate within the astrocytes toward the astrocytic endf
and/or -constrictors. As such, astrocytes are important players in neuron-to-vessel signaling. Aga
response along the vessel wall. Finally, in pathological conditions, astrocytic Ca2+ signals may b
portance in this process. Microglia may also be activated by damage-associated molecules, a
the release of pro-inflammatory molecules that will signal back to astrocytes, contributing
glutamate/aspartate transporter; GLT-1, glutamate transporter 1; HC, hemichannel; IP3, inosit
K+ channel; NKCC, Na+/K+/Cl- cotransporter; Na/K, Na+/K+-ATPase; PGE2, prostaglandin E2;derived from the ER involving both IP3Rs and RyRs [213], but also in-
volves Ca2+ influx from the extracellular environment, likely mediated
by TRPC1 channels [214]. Additionally, mitochondria modulate exocy-
totic glutamate release from astrocytes, since inhibiting mitochondrial
Ca2+ accumulation increases [Ca2+]i and enhances glutamate releasetions. By removing and recycling byproducts of action potential firing, including glutamate
, astrocytes are activated by neurotransmitters like glutamate towhich they respondwith
y influence synaptic activity and neuronal circuit plasticity. The increase in [Ca2+]i can be
h will allow astrocytes to modulate remotely located synapses. The Ca2+ signal raised by
eet that surround the blood vessels. Here, Ca2+ will stimulate the release of vasodilators
in, the propagation of Ca2+ signals betweenwell-coupled endfeetwill allow a coordinated
e involved in the activation of microglia. ATP release, possibly via HCs, is of significant im-
ll of which lead to a microglial Ca2+ increase. This rise in [Ca2+]i may ultimately lead to
to astrogliosis. (20-HETE, 20-hydroxyeicosatetraenoic acid; GJ, gap junction; GLAST,
ol 1,4,5-trisphosphate; mGluR, metabotropic glutamate receptor; Kir, inwardly rectifying
PRR, pattern recognition receptor; ROS, reactive oxygen species).
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and its subsequent modulation of synaptic activity is challenged by a
study performed on IP3R2 KOmice [216]. Several lines of evidence sug-
gest that this subtype is the primary IP3R expressed by astrocytes [217,
218]. Ablating IP3R2 eliminates both spontaneous and GPCR-mediated
increases in astrocytic Ca2+, while neuronal GPCR-dependent Ca2+ in-
creases remain intact. However, silencing astrocyte Ca2+ signaling pro-
voked by IP3R2 KO did not significantly affect perisynaptic glutamate
levels nor did it alter excitatory CA1 pyramidal neuronal synaptic
activity [216].
At the vascular side, astrocytic Ca2+ signaling links to blood flow reg-
ulation, metabolic trafficking, BBB function and water homeostasis [50].
In situ, astrocytes express P2Y2 and P2Y4 receptors and Cx proteins,
both involved in Ca2+ signaling, as well as aquaporin 4 (AQP4) involved
in water homeostasis at their perivascular endings [50]. This extraordi-
nary high expression of basic Ca2+ signaling elements supports wave-
like propagation of Ca2+ signals between rows of endfeet to influence
vascular SMCs and blood vessel diameter, as observed in brain slices
[219]. At present, it is not knownwhether endfeet Ca2+ signaling also in-
fluences capillary endothelial cells and BBB function. Cell culture studies
have suggested propagation of ICWs between astrocytes and endothelial
cells [68,220] but this could not be confirmed in cortical slice studies [50].
Possibly, this is related to the presence of the basal lamina interposed be-
tween endothelial cells and astrocytes, and the fact that ATP is a short-
distance messenger that is rapidly degraded by ectonucleotidases [221].
The evidence that neuronal activity-triggered astrocytic Ca2+ signal-
ingmodulates arteriolar blood flow is particularly strong and supported
by brain slice as well as in vivo animal studies [194,222–224], although
at least one recent study challenges this view [225]. Electrical stimula-
tion of neuronal afferents results in the activation of astrocytic metabo-
tropic glutamate receptors (GluRs), giving rise to a [Ca2+]i increase and
release of PGE2 that induces a vasodilation of adjacent cortical arterioles
[223,224,226]. Follow-upwork indicated that the [Ca2+]i increase in as-
trocytes is pursued by [Ca2+]i changes in vascular SMCs: vasodilation
was accompanied by a suppression of Ca2+ oscillations in SMCs, likely
mediated by astrocyte-derived carbon monoxide. The SMC response is
furthermore abolished in isolated arterioleswhere astrocytes are absent
and in brain sliceswhere astrocytes are ablated by the gliotoxin L-alpha-
aminoadipic acid (L-AAA), that is reported to target astrocytes by a yet
unknown mechanism [38,227–229]. Astrocytic [Ca2+]i changes have,
in addition to triggering vasodilation, also been reported to provoke va-
soconstriction mediated by the arachidonic acid metabolite 20-
hydroxyeicosatetraenoic acid [219]. One explanation for these opposite
vascular reactions relates to perivascular K+ levels. The threshold con-
centration of perivascular K+ for inducing a vasodilatory response is
20 mM. When [K+] exceeds this threshold, the vascular respons con-
verts into a constrictive one. Large conductance Ca2+-sensitive K+
channels, that are strongly expressed in astrocytic endfeet [230], are de-
cisive in determining these perivascular K+ levels [231,232]. Another
explanation is related to oxygen availability. The vasodilatory response
to astrocytic [Ca2+]i elevation is favored by low oxygen availability,
which results in increased astrocytic glycolysis and consequent lactate
release. This stimulates the extracellular accumulation of vasodilatory
PGE2 and adenosine [233]. Astrocytic lactate release may also result
from the uptake of synaptically derived glutamate, thereby boosting
glycolysis and contributing as a Ca2+-independent astrocytic influence
[226]. A differential vascular effect of astrocytic [Ca2+]i elevation may
be responsible for an increased blood flow in areas experiencing neuro-
nal activation while reducing the flow to inactive regions vascularized
by vessels branching from the same artery. Importantly, the extent of
vasomotor responses seems to depend on the number of endfeet that
are activated [222]. Spatially confined [Ca2+]i changes confer a dimen-
sionally restricted control over the arteriolar diameter [194,219,224,
234]. By contrast, a sufficiently large increase in [Ca2+]i is capable of in-
ducing an ICW that propagates along foot processes enwrapping the
vascular wall, thereby mediating a more expanded vascular response[50,219] which might be involved in the vasodilation of upstream pial
arteries [235]. The role of glial Cx channels in this process remains to
be fully established but at least one report highlights the necessity of
Cx43 in vasodilatory responses [59]. It is unknown whether this con-
cerns endothelial or astrocytic Cx43 but vascular Cx37 and Cx40 at
least did not appear to be involved.
Alterations in local blood flow in response to neuronal activity are
known as functional hyperemia or neurovascular coupling, and secure
an adequate supply of glucose and oxygen under conditions of in-
creased demand. Neurovascular coupling is adjoined by coupling of
neuronal activity to changes in energymetabolism that is compartmen-
talized in astrocytes and neurons. According to the classical view, glu-
cose is the main fuel for both neurons and astrocytes. However, this
view has been challenged by the astrocyte–neuron lactate hypothesis
which states that the uptake of glucose predominantly takes place in as-
trocytes. Subsequently, lactate is produced by astrocytes in an activity-
dependent, glutamate-mediated manner, and is transferred to active
neurons, where it's been converted into pyruvate that fuels the Krebs
cycle [236–239]. Additionally, coupling to transport over BBB endothe-
lial cells, dubbed neurobarrier coupling, has also been proposed [238,
240]. Each of these processes may be regulated by changes in [Ca2+]i
as well [241–245].
5. Aberrant Ca2+ signaling in neurogliopathologies
Spontaneous ICWs have been observed in vitro in cultured astro-
cytes starting from the 90s [184]. However, it is speculated that such
spontaneous ICWs are probably an artifact of cultured cells [246]. In par-
ticular, the intensity/duration of the stimuli required to evoke these
ICWs in vitro is often in a supraphysiological range [9]. Although fre-
quently observed in cultured cells, several authors did not observe
ICWs under basal/physiological levels of neuronal activity in vivo [21,
22,25,194,195]. In contrast, a handful of publications have reported
the occurrence of ICWs in vivo in several disease states such as ischemia
[20], epilepsy [25,26], AD [21,22], brain trauma [23,24] and cortical
spreading depression [247] (Table 3), suggesting that pathological con-
ditions aremore favorable toward the triggering and/or the propagation
of ICWs. However, many important questions still remain: how are these
glial ICWs initiated, how are they propagated (paracrine versus GJIC) and
howdo glial ICWs contribute to the pathogenesis and disease progression?
5.1. Pathological triggers as potent inducers of intercellular Ca2+ waves
A decrease in [Ca2+]e, known to evoke ICWs [187,248], has been re-
ported to occur in hypoglycemia, ischemia, epilepsy, and CNS trauma
[249–252]. In addition, mild declines in brain interstitial Ca2+ levels
may take place in response to neuronal stimulation [253,254]. Various
trigger mechanisms for the low [Ca2+]e-induced ICWs have been pro-
posed with the most plausible one pointing to CxHC mediated ATP re-
lease that acts as a point source from trigger cells [169]. Mechanical
stimulation and trauma induce ICWs that can propagate hundreds of
μm in in vitro model systems, depending on the magnitude of the stim-
ulus [23,24,255,256].Wave-like Ca2+ dynamics in vivo generally appear
to involve tens of astrocytes [16,26,257]. Amyloid-β (Aβ)-peptide, the
major component of senile plaques in Alzheimer patients, increases
the amplitude, velocity and distance of ATP- and GJ-mediated ICWs in
astrocyte cultures [258]. Moreover, pathologically relevant concentra-
tions of Aβ (nM to μM range) were able to induce astrocytic ICWs with
a delay of minutes, suggesting a reorganization in terms of chemical
Ca2+ excitability threshold and/or communication properties of the in-
tercellular network [259]. Of note, picomolar amounts of Aβ that are
not associatedwith pathology, do facilitate spontaneous Ca2+ transients
in astrocytes but do not affect ICW parameters [260], pointing to an in-
crease in Ca2+ excitability. In amyloid precursor protein (APP)/presinilin
1 (PS1) double transgenic mice that express mutant human PS1-ΔE9
and chimeric mouse/human APPswe, Aβ plaques nearly double
Table 3
Overview of triggers and mechanisms involved in in vivo intercellular Ca2+ signaling.
Trigger Cell typesa Propagation mechanism Remarks Reference
Spontaneous
Astrocytes/neurons ND ICWs observed in astrocytic network [17]
Hippocampal astrocytes Purinergic signaling/Cx
channels
High-speed ICW-like propagations (‘glissandi’) involving hundreds
of astrocytes
Glissandi depend on neuronal activity
Associated with a reduction in blood flow
[18]
Retinal glia Purinergic signaling ICWs propagated through Müller cells, not through astrocytes
Aging increases spontaneous ICWs due to more ATP release
Associated with a reduction in blood flow
[196]
Bergmann glia ND Aging increases spontaneous ICWs
Accompanied by [Ca2+]i increases in Purkinje neurons, but no
change in neuronal activity
Reduces brain oxygen tension
[19]
Bergmann glia Purinergic signaling Recurring waves extend from the same foci [16]
Neuronal activity
Bicuculline (GABAA receptor blocker) Astrocytes [193]
Whisker stimulation Astrocytes Glutamatergic signaling No ICWs reported [195]
Visual stimuli Astrocytes Glutamatergic signaling No ICWs reported [194]
Glutamate uncaging/visual stimuli Microglia Neuronal Panx1 HCs/
purinergic signaling
No ICWs reported
Microglia migrate to and make contact with activated neurons
Microglial–neuronal contact downregulates neuronal activity
[384]
Ischemia
Photothrombosis Astrocytes Glutamatergic The Ca2+ chelater BAPTA-AM reduced the infarct volume [20]
Alzheimer's disease
APP/PS1 mice Astrocytes ND Astrocytic [Ca2+]i elevated, independently from distance to Aβ plaques
ICWs induced near plaques and spread radially
[21]
3xTgAD mice
PDAPP mice
Astrocytes ND In contrast to ADmice, no spontaneaous ICWs or ICWs in response to
photo-activation of IP3 were observed in control mice
[22]
Traumatic injury
Brain cortical impact Astrocytes Purinergic signaling Influences neuronal network activity and evokes neuronal death as
evidenced from experiments conducted on neuron–glia co-cultures
and organotypic slice cultures
[24]
Laser ablation ND Glutamatergic signaling ICWs not dependent on ATP or Cx channels
ICW-evoked ATP release attracts microglia
Local photo-activation of caged IP3 mimicks the microglial injury
response
[23]
Laser ablation/mechanical injury Astrocytes Purinergic signaling/Cx
channels
Polarized Ca2+ gradient in astrocytes that guides microglia to the
injury site
No ICWs observed
[376]
Epilepsy
Pilocarpine-induced status epilepticus Astrocytes Glutamatergic signaling Evoke neuronal cell death
Astrocytic Ca2+ signals are dependent on metabotropic mGluR5,
while neuronal cell death relies on NMDAR activity
[25]
4-Aminopyridine-induced seizures Astrocytes ND Evokes PDSs through glutamate release [26]
Cortical spreading depression
High [K+]e Neurons/astrocytes ICWs are observed in neurons and in astrocytes
Astrocyte ICWs evoke vasoconstriction of intracortical vessels
[247]
a In which the Ca2+ responses were studied. (Aβ, amyloid-β; APP, amyloid precursor protein; BAPTA-AM, 1,2-bis(2-aminophenxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester; Cx,
connexin;HC, hemichannel; ICW, intercellular Ca2+wave;mGluR,metabotropic glutamate receptor; NMDAR,N-methyl-D-aspartate receptor; PDS, paroxysomal depolarization shift; PS, presinilins)
2219M. De Bock et al. / Biochimica et Biophysica Acta 1843 (2014) 2211–2232astrocyte resting [Ca2+]i and promote spontaneous Ca2+ activity that is
communicated radially over at least 200 μm along the astrocytic net-
work [21]. The ICWs do not rely on the presence of hyperactive neurons
near the plaques [21,261], indicating that the increased astrocytic Ca2+
excitability is induced by Aβ exposure itself and is not the result of an
enhanced electrical excitability of neurons. The augmentation in astro-
cyte [Ca2+]i in response to Aβ can be mediated by Ca2+ store release
(IP3- and RyR-dependent) and SOCE [262]. Additionally, Aβ has been
shown to bind the Ca2+-sensing receptor, a GPCR that senses extracellu-
lar Ca2+ levels [263], or to enhance spontaneous Ca2+ signaling via nic-
otinic acetylcholine receptors in astrocytes [260]. Alternatively,
intracellular accumulation of Ca2+ may be mediated by the pore-
forming capacity of Aβ protein or possibly by creating a non-selective
Ca2+ entry route by inducing oxidative stress and lipid peroxidation of
the plasma membrane [264,265].
Another potential trigger for ICWs may originate from areas of cell
death. Most, if not all, brain diseases are associated with cell deaththat is accompanied by the release of ATP and glutamate from the intra-
cellular metabolic pool [266]. These neural/glial transmitters activate
ionotropic and metabotropic receptors, with subsequent Ca2+ entry
and IP3-triggered ER Ca2+ release that may trigger ICWs [169–173,
184,186]. Work from our research group on cultured glioma cells, has
brought forward that both Cx43 GJs and HCs are involved in communi-
cating cell death messages from cells undergoing apoptosis to healthy
neighboring cells, a process known as ‘bystander cell death’ [267]. Im-
portantly, we demonstrated that the passage of the Ca2+ messenger
IP3 through GJs is crucial for intercellular cell death communication.
This work provided evidence that the physiological messenger IP3 be-
comes a pathological intercellular messenger when the cells generating
IP3 are exposed to proapoptotic conditions [268,269]. Recentwork from
others supports this concept and demonstrates that HIV infection of as-
trocytes results in bystander apoptosis of uninfected astrocytes via the
IP3/Ca2+ signaling axis [270]. Thus, IICR is required for normal function
and cell survival, but it can also be actively involved in apoptosis
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mitochondrial Ca2+ transfer at the level of the MAMs plays a major
role in cell death by providing proapoptotic Ca2+ transfer via IP3R inter-
action with VDAC1 [143,272–276]. Additionally, numerous factors in-
volved in apoptosis have been located at the ER–mitochondrial
interface and modulate cell survival by directly or indirectly regulating
IICR [277,278]. Recent evidence revealed that alterations in ER–
mitochondrial Ca2+ communication, possibly by regulating IICR, may
represent a common hit in several brain pathologies including ischemia
[279,280] and neurodegenerative diseases such as AD and Parkinson's
disease [150,281–286]. Although neurons themselves are the primary
target of investigation in these studies, an increasing number of publica-
tions have demonstrated alterations in ER Ca2+ signaling in astrocytes,
primarily in ischemic conditions and AD [280,287–290]. While the con-
tribution of GJs to bystander cell death is straight forward, i.e. they facil-
itate the direct exchange of cell death and cell survival signals between
cells, the role and functional consequences of HC opening on cell death
is still poorly defined. Several possibilities have been put forward:
(i) HC opening may help in setting off cell death by the excessive entry
of Ca2+ or other toxic molecules and (ii) being a pore permitting diffu-
sion in both directions, HCs could also contribute via the release of sur-
vival molecules or, more indirectly, via the release of paracrine
messengers which induce a [Ca2+]i rise in more distant cells [291,292].
Disturbances in astrocyte Ca2+ signaling combined with Cx-
mediated Ca2+ signal communication may thus act to expand cell
death and neurodegeneration. As discussed in the next sections, ICWs
may possibly be involved in expanding the processes of reactive
astrogliosis and microglial activation as well. The balance between
astrogliosis, microglial activation and neurodegenerationmay ultimate-
ly determine the level of destruction, neuroprotection and regeneration
resulting from the pathological process.
5.2. A role for Ca2+ and connexins in astrogliosis?
Reactive astrogliosis, a defensive astrocytic response, is a common
feature of many CNS disorders, including stroke, trauma, epilepsy, neu-
rodegeneration, infection and autoimmunity [293]. However, despite its
widespread observation, the role of as well as the cellular changes ac-
companying astrogliosis are poorly understood. Reactive astrogliosis is
generally regarded as a defensive reaction towards injury which aims
at isolating the damaged area from the rest of the brain tissue to facili-
tate restoration of the tissue surrounding the lesion. It generally appears
as a hypertrophy and/or proliferation of astrocytes surrounding the le-
sion. Based on the severity of the changes, reactive astrocytes can be
subdivided in two different classes, anisomorphic and isomorphic
[294]. Anisomorphic astrocytes are characterized by robust hypertro-
phy and proliferation and evolve towards the formation of glial scar tis-
sue that is composed of astrocytes and extracellular matrix [295]. Glial
scar tissue surrounds the injured/lesioned tissue site andmay therefore
prevent its extension but it also plays a key role in regeneration failure
because it inhibits axonal sprouting. In isomorphic astrocytes, the reac-
tive changes are milder and often reversible, allowing regeneration of
the tissue.
The upregulation of intermediate filament proteins, including glial
fibrillary acidic protein (GFAP) and to a lesser extent nestin and
vimentin, are often used as indicators for astrogliosis [296]. Other
changesmay appear in a context/disease-specificmanner [297]. It is im-
portant to realize thatmany proteins associatedwith Ca2+ signaling are
altered in reactive astrocytes. Genetic profiling of the astrocyte response
towards pro-inflammatory mediators such as TGF-β and IFN-γ has re-
cently uncovered the specific responses of different GPCRs towards in-
flammation and has revealed pronounced changes in the Ca2+
household during astrogliosis [298]. Likewise, an upregulation of the
Ca2+-entry channel TRPV4 coincides with the onset of astrogliosis dur-
ing an hypoxic/ischemic insult [299], whereas the L-type Ca2+ channel
CaV1.2 is upregulated in reactive astrocytes surrounding Aβ plaques[300]. Most interestingly, in several models, Ca2+ appears to be one of
the early injury signals that initiates the signal transduction cascade
for astrogliosis; e.g. through ER Ca2+ store release (via IP3Rs and
RyRs) and SOCE in Aβ-treated astrocytes [259,262] or following lipo-
polysaccharide (LPS) exposure [301], and through IICR [302] and Ca2+
influx in response to spinal cord and brain injury [303,304].
Cx43 is also reported to be one of the proteins modified in reactive
astrocytes. Increased Cx43 expression has been detected in regions
with astrogliosis induced by various CNS diseases including brain injury
[305–308], spinal cord injury [309,310], brain ischemia [311,312], AD
[313], epilepsy [314,315], and also following retinal ischemia [316,
317]. Cx43 deletion in astrocytes causes a reduction of astrogliosis in
brain ischemia and brain/spinal cord injury models [306,309,
318–321]. Inversely, astrocytic Cx43 was decreased in the spinal cord
of experimental autoimmune encephalomyelitis (EAE) mice (a model
for multiple sclerosis [322]), and in response to a cortical lesion induced
by kainic acid injection [323]. Thus, Cx43 may be up- or down-
regulated, depending on the type of brain pathology, but probably also
on the time scale, and the distance from the lesioned area. For example,
excitotoxic induction of neuronal cell death in vivo lead to a strong de-
crease of Cx30 and Cx43 in reactive astrocytes located within the
neuron-depleted zone, whereas increased Cx expression was found in
reactive astrocytes at the periphery of the lesion [51]. Transient Panx2
expression was observed in reactive astrocytes in the hippocampus of
adult rat brain subjected to ischemia/reperfusion injury [324].
There is limited evidence that ICWs could contribute to the genera-
tion of reactive astrocytes and glial scars e.g. after traumatic injury
[255], ischemia [20], and Aβ exposure [259]. One paper has demonstrat-
ed an involvement of Cx-mediated ICWs to the expansion of astrogliosis
[304]. Scratch injury applied to mouse cortical astrocyte cultures in-
duced a [Ca2+]i elevation along the scratch via Ca2+ entry, which was
then disseminated to neighboring astrocytes as an ICW propagating
via GJs. These increases in [Ca2+]i switched on the JNK/c-Jun/AP-1 path-
way to upregulate GFAP expression. Dampening the [Ca2+]i changes
with intracellulary-loaded BAPTA in an in vivo stab wound model, re-
duced the expression of GFAP and the extent and size of glial scars,
supporting the involvement of Ca2+ signaling [304].
5.3. Neuronal cell death, a consequence of astrocyte network distortion?
Excitotoxicity, induced by excessive glutamate release and subse-
quent activation of Ca2+ and ROS signaling, is a major trigger for neuro-
nal cell death [325,326]. Astrocytes coupled by GJs normally act to
promote neuronal survival after a pathological insult by scavenging
ROS (astrocytes contain high concentrations of antioxidant molecules
such as glutathione and ascorbate) and by spatial buffering of extracel-
lular K+ and glutamate as set out in Section 3. However, as things get
rough, glial homeostatic mechanisms can be altered which rapidly pro-
vides the astrocytic network with killer functions including the exacer-
bation of neuronal damage by decreased glutamate or K+ uptake or by
increased release of glutamate, ATP or inflammatory cytokines [319,
327–331]. Most notably, ICWs spreading over the astrocytic network
may promote astrocytic release of thesemessengers therebyworsening
neuronal damage. The dual role of astrocytes implicates that a precise
regulation of their response may determine the outcome of CNS
pathology.
Astrocytic ATP release combined with extracellular glutamate accu-
mulation promotes neuronal cell death [327] and at millimolar extra-
cellular ATP concentrations it contributes to astrocytic cell death via
the activation of P2X7 receptors [332]. On the other hand, ATP is rapidly
degraded to adenosine, which can affect neuronal functioning as it in-
hibits excitatory activity and presynaptic neurotransmitter release
[254,333]. ATP may also contribute to myelin disturbances and axonal
degeneration; ischemia-induced oligodendroglial death shows hall-
marks of a Ca2+-dependent excitotoxic pathwaywhich involves the ac-
tivation of N-methyl-D-aspartate receptors (NMDARs) and P2X7
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[334]. Panx1 channels were also suggested to function as large pores as-
sociated with the P2X7 receptor [335,336], including in astrocytes [93].
Panx1 co-immunoprecipitates with P2X7R and inhibition of Panx1 pre-
vents P2X7R-mediated dye uptake [335,336]. In addition, functional
NMDAR have been identified in astroglial cells (reviewed in [337])
and excess activation results in a Ca2+ influx that may spread through
GJs composed of Cx43 and Cx47 to oligodendroglia, evoking apoptosis
in the latter [338]. Finally, astrocytes produce and release awide variety
of inflammatory molecules including cytokines, chemokines and pros-
taglandins [339–341], which provides a mutual communication path-
way between astrocytes and microglia (see Section 5.4). Astrocytes
may be involved in anti-inflammatory processes including scar forma-
tion [342], or pro-inflammatory cytokine release may damage cells by
e.g. increasing the Ca2+-dependent release of glutamate [343]. Among
the cytokines expressed by astrocytes, interleukin-1β (IL-1β) and
tumor necrosis factor-α (TNF-α) have received considerable attention
because they activate CxHCs and exert pro-inflammatory effects in the
CNS [331,344]. Inhibition of Panx1 prevents activaton of innate immu-
nity and secretion of pro-inflammatory cytokines through the pattern
recognition receptors NLRP1 and NLRP2 [345,346]. Panx1 channels,
P2X7 receptors and CxHCs may thus act in concert during the course
of neuroinflammation.
5.4. Neuroinflammation, a combined effort between activated astrocytes
and microglia
Ischemia, trauma and neurodegenerative diseases such as AD, amyo-
trophic lateral sclerosis (ALS), Huntington's disease and Parkinson's
disease are some of the pathologieswhich are accompanied by inflamma-
tory events [347,348]. Microglial cells form the innate immune defense
system of the CNS. They continuously scan the brain parenchyma for
damage signals by which they are activated. Once activated, microglial
cells migrate to the site of injury, proliferate, and phagocytize cells and
cellular compartments [349]. They accumulate around degenerating neu-
rons and reactive astrocytes in various CNS disorders [347,348] and show
diverse activated phenotypes depending on the pathology and the dam-
age signal or chemoattractant that is released [350,351]. The best
known chemoattractant sensed by microglia is ATP [352]. Several neuro-
peptides such as angiotensin II, bradykinin, endothelin, galanin and
neurotensin are also chemoattractants for microglia [353]. Most of these
molecules activate microglia by triggering a [Ca2+]i elevation via plasma
membrane Ca2+ channels such as ionotropic P2X receptors, IICR and
the reverse mode of the NCX [351,354]. Microglia can also be activated
by an Aβ-induced [Ca2+]i surge, after which they secrete pro-
inflammatory and neurotoxic factors [355,356].
Activated microglia release a large number of substances including
ATP, glutamate, cytokines like TNF-α, superoxide radicals and
neurotrophins that can either act detrimental or beneficial for the sur-
rounding cells. They communicate with neurons and macroglial cells
through paracrine factors [357]. Activated microglia express Cx32,
Cx36 and Cx43 [357]. It is conceivable that the paracrine signalingmol-
ecules, some of which have a MW b 1.5 kDa, may be released via HCs.
There is in vitro evidence for microglial glutamate release via HCs
upon exposure to TNF-α [358]. Blocking HC-mediated glutamate re-
lease via different pharmacological substances (see Section 5.5) further-
more protects neurons from ischemic brain injury, attenuates EAE, and
suppresses disease progression in ALS and AD mice in vivo [359–361].
Astrocytes can rescue neurons from microglial glutamate-induced
death [362] but their glutamate-uptake capacity can also be hampered
by microglial glutamate release via downregulation of the astrocytic
GLAST glutamate transporter, therebyworsening extracellular accumu-
lation of glutamate [363]. Cx32 HCs have been implicated in the release
of glutamate frommicroglia [358]; however, at present, evidence for the
expression and functional role of Cx32 remains poor. HCs composed of
Cx43 are other candidates for mediating the release of paracrinemessengers. This Cx is not expressed in quiescent microglial cells, but
it is upregulated upon their activation, suggesting a role during inflam-
mation. It has been recently shown that ATP release via microglial Cx43
HCs is involved in microglial death [364]. Finally, although GJs have
been described in cultured microglial cells [365], GJIC between
microglial cells as well as with other surrounding cells has recently
been reported to be absent in vivo [366].
Conditioned media from activated microglia or direct application of
amixture of the pro-inflammatory cytokines TNF-α and IL1-β influence
the Cx-based astrocytic communication network: GJIC is reduced while
HCs are invariably reported to open [78,331,344,367–369]. Effectwise,
the reduced GJ coupling will restrict the movement of glucose and lac-
tate over the astrocytic network while the open HC pathway may pro-
vide non-specific glucose uptake from the interstitium [49,78]. The net
balance of these diverse effects is currently not clear, but they might
have serious implications for the metabolic status of astrocytes in
brain inflammation. In terms of ICWs, pro-inflammatory cytokines can
shift the ICW supportive pathway from GJIC to paracrine mechanisms
[370]. Cytokines released by astrocytes can also influence microglial
Ca2+ signaling [371] and were demonstrated to increase GJIC and in-
duce HC opening in microglial cells [372,373].
[Ca2+]i increases evoked by danger signals can propagate as ICWs,
thereby possibly expanding inflammation. A recent study in
zebrafish larval brain revealed that laser light-induced neuronal in-
jury initiates an ICW that travels throughout the brain and attracts
microglia to migrate to the injury site. Here, glutamate-dependent
ICWs establish an ATP guidance cue that is responsible for transmit-
ting positional information across the brain to P2Y12-expressing mi-
croglia [23]. The propagation of the ICWs did not depend on Cx
channels and ATP signaling, which contrasts with the observation
that chemotactic microglial activation in mice is reduced by Cx chan-
nel blockers [374]. Although neurons, oligodendrocytes and endo-
thelial cells are all candidates for releasing ATP upon injury,
astrocytes are suggested to be the main cell type responsible for
the rapid and long-range microglial response towards injury. Astro-
cytic ICWs trigger microglial responses in brain slices which appear
to depend on the release of ATP [200,375]. Kim and Dustin [376] re-
ported that laser-induced necrotic injury in vivo inducesmorpholog-
ical changes in astrocytes that were accompanied by a [Ca2+]i
gradient (but not ICWs) in the direction of the injury site. The astro-
cyte polarization and Ca2+ response was proposed to guide
microglial cells and was blocked by ATP and Cx channel blockers.
Panx1 channels have also been extensively studied as ATP releasing
pores. They seem to play a key role in the release of this “find-me” signal
from apoptotic cells for phagocytotic clearance [377,378]. Panx1 chan-
nels can be activated in cultured neurons and astrocytes, and in hippo-
campal slices, by elevated [K+]e, which can occur during different
pathological conditions including epilepsy [379,380]. They have been
proposed to mediate astrocytic ICWs via the release of ATP [94,181]. In
leeches, nerve injury induces ICWs in glial cells and ATP release through
channels composed of innexins, the invertebrate analogues of Cxs. Ex-
tracellular ATP then activates microglia and initiates microglial move-
ment [256]. The injury site is also characterized by a delayed release of
arachidonic acid, which blocks ATP release from glia after nerve injury
and thereby stops microglia at lesions [381]. Panx1 has furthermore
been implicated in the activation of the inflammasome, a multiprotein
complex involved in innate immunity, in astrocytes and neurons
[379]. Moreover, a number of studies have supported the idea that
Panx channels are the pore-forming component of the P2X7 receptor,
with prolonged stimulation resulting in cell death [334,335,382]. Of
note, from several studies it is also clear that extracellular ATP release
not only mediates a rapid microglial response towards injury but it
also regulates microglial branch dynamics in the intact healthy brain
[374,383]. By imaging the visual center optic tectum in living larval
zebrafish, Li and co-workers recently demonstrated a bi-directional reg-
ulation between resting microglia and neurons: a local increase in
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nels, which attracts restingmicroglial processes and drives them to con-
tact neurons with high levels of activity. The microglia–neuron contact
in turn reduces the activity of contacted neurons [384].
5.5. Connexin-mediated communication, gap junctions versus hemichannels
Cx-mediated intercellular communication has been suggested to
support the propagation of both pro-survival and pro-cell death mes-
sengers [291].While treatments that suppress Cx43-based communica-
tion can re-inforce neurotoxicity in some models of neurodegenerative
conditions [385,386], they may also be neuroprotective [318,319,387,
388]. These opposite functions could relate to differences in the model
systems used [291]. It should be noted that many of these observations
were based on the use of non-specific channel blockers and/or genetic
silencing of Cx expression, which affect both GJ and HC functioning. In
addition, the genetic silencing of Cxs canmodulate the expression levels
of other proteins. It was recently demonstrated that the Cx43 and Cx30
deficiency in double KOmice differentially affects the expression of glial
glutamate transporters depending on the brain region studied [389]. As
such, more appropriate experimental tools are crucial to gain insight
into themechanisms viawhichCxs affect cellular injury, e.g. by applying
specific blockers that affect HCs or GJs only. Certain peptides derived
from the Cx43 protein sequence can act as selective inhibitors of Cx
channels [390–392]. Peptides targeting the extracellular loops that in-
hibit HCs withinminutes and GJs after several hours [393], are available
for Cx26, Cx32, Cx37, Cx40 and Cx43 [392,394,395]. The Cx mimetic
peptides Gap26 and Gap27, derived from the Cx43 sequence, have
been used extensively to inhibit Cx channels in glial cells, giving rise
to various effects such as inhibiting glutamate and ATP release,
protecting neurons from excitotoxicity, inhibiting apoptosis and
influencing neuroinflammation [86,267,331,344,396]. In addition,
other peptides identical to sequences on the intracellular parts of the
Cx43 protein have been exploited to specifically inhibit HCs without
influencing GJs [390,397,398]. Cx43 targeting peptides have been dem-
onstrated to resort to beneficial effects in in vitro and in vivo models of
CNS pathologies, including brain and retina ischemia [316,399,400], ep-
ilepsy [388,401], AD [402], optic neuropathy [403], spinal cord injury
[319,404], and inflammation-induced BBB permeability [394].
5.6. Astroglial intercellular Ca2+ waves, a common factor
in neurodegeneration?
The vast majority of research tackling the question of the Cx/Panx
channel contribution to cell death has been performed in the context
of the CNS. An increasing number of reports demonstrate a profound ef-
fect of pathological conditions on the expression of glial Cxs and Panxs,
in particular Cx43 and Panx1, and their function as channels in a range
of CNS diseases including epilepsy, traumatic brain and spinal cord inju-
ry, AD, and ischemia-related injury [405–410]. Below, we discuss the
role of ICWs and Cx/Panx alterations in each of these disease states.
5.6.1. Brain ischemia
Cx-mediated intercellular communicationmaymodulate the gradu-
al expansion of cell death, as has been well-exemplified in the case of
ischemia-induced injury. Although neurological cell death occurs with-
in seconds to minutes after the ischemic insult in the core region, the
progression of ischemic injury and cell death can continue for hours
and days, thereby expanding the infarct region to the surrounding
area termed the penumbra [411–414]. The latter is characterized by
the presence of viable, yet metabolically compromised, cells that can
be rescued by either restoring/improving perfusion or by counteracting
neuronal damage. Many conceptually promising, therapeutic strategies
based on targeting a variety ofmolecular cell injury/cell death pathways
in neurons have failed in human studies, mainly because messengers
causing destruction are also necessary for remodeling and repairafterwards [415]. Thus, specific messengers leading to cell injury need
to be targeted at the right time before they adopt beneficial roles. Addi-
tionally, focus has shifted from the neurons towards the astrocytes,
which are considered today as novel therapeutic targets [416–418]. As-
trocytes are more resilient to ischemic injury compared to neurons,
most likely due to their high levels of antioxidants and their prominent
anaerobic energy metabolism [237,419]. However, once the astrocytic
network fails, glutamate/K+ clearance and energy delivery through
the astrocyte–neuron lactate shuttle will stop and active release of neu-
rotoxic mediators may start [235,236,239,420–422]. Hence, astrocyte-
network distortion can critically contribute to neuronal death.
Cxs have been suggested to contribute to the wave of delayed sec-
ondary injury that spreads from the core region to the penumbra.
Most studies emphasize a role for glial Cxs [408,423–426] but evidence
for a contribution of neuronal GJs composed of Cx36 is accruing as well
[42,427]. Ischemia-related injury is mostly associated with a reduction
of astrocyte GJIC and an aberrant opening of Cx43 HCs [84,344,400,
428,429]. However, despite the reduction in GJIC, there is evidence
that a subset of GJs remains open and thus available for transferring
cell death or survival signals under ischemic conditions [84,291,292,
430]. Additionally, GJs may contribute to the propagation of cortical
spreading depression (CSD), which consists of waves of tissue depolar-
ization (20–80 μm/s) that have been linked to an increase in infarct vol-
ume after an ischemic insult [57,431–433]. CSD has been associated
with slower propagating ICWs in astrocytes in vitro [190,434,435],
andmore recently also in vivo [247]. Here, CSD-associated ICWs first oc-
curred in neurons but this was tightly coupled to a preceding ICW in as-
trocytes and to the vasoconstriction of intracortical arterioles [247]. The
opening of Cx43 HCs will not only lead to astrocyte dysfunction and cell
death by a collapse of membrane potential and the entry of Ca2+ [84,
400,428,429], but will additionally allow the escape of glutamate and
ATP that may further promote cell death [291,292,424].
Evidence for ICWs contributing to the expansion of brain infarction is
also available. In response to photothrombosis-induced ischemia, cortical
astrocytes in vivo showed large repetitive and transient Ca2+ signals
within 20 min after photothrombosis which lasted up to 3 h [20]. They
were synchronized and propagated as ICWswithin the glial network, giv-
ing rise to Ca2+ signals in astrocytes in the penumbra. In contrast to neu-
rons, astrocytes in the ischemic core retained their structural integrity for
hours while an increase in reactive astrocytes was observed in the pen-
umbra. Cortical loading of the Ca2+ buffer BAPTA into astrocytes signifi-
cantly reduced the infarct volume. The astrocytic Ca2+ signals were
triggered by mGluR5 and GABAB receptors [20]. A reduction of brain ox-
ygen tension evokes increased frequency of spontaneous cerebellar
ICWs in Bergmann glia in vivo, and [Ca2+]i increases in Purkinje neurons
[19]. Several authors have reported a role for astrocytic IP3Rs inmodulat-
ing ischemic damage. IICR is shown to be neuroprotective since the ische-
mic damage was aggravated in IP3R2 KO mice which abolish astrocyte
Ca2+ dynamics [218]. Finally, treatment with 2-aminoethoxydiphenyl
borate, an inhibitor of IICR, decreased spontaneous Ca2+ oscillations in
both astrocytes and neurons, and induced ischemic tolerance via a
down-regulation of the glutamate transporter-1. A subsequent build-up
of extracellular glutamate desensitizes the cells to the ischemia-induced
glutamate increase [436]. An important issue to take into account is that
2-aminoethoxydiphenyl borate has off-target, inhibitory effects on Cx
channels [437] and SOCs [438].
ICWs may be initiated by excessive neuronal firing or cell injury in
the lesioned area. Once they are activated, theymay self-sustain and ex-
pand [Ca2+]i increases over larger populations, resulting in an expan-
sion of the damaged area. However, as evidenced by a recent paper,
astrocyte Ca2+ signaling is not necessarily a bad thing. In response to
an ischemic insult, astrocytes in the contralateral hemisphere experi-
ence a boost in Ca2+ signaling which contributes to enhanced uptake
of glutamate, thereby eliminating the excitotoxic trigger [439]. As con-
tralateral astrocytes are not subject to energy deprivation this gluta-
mate may be converted to glutamine and shuttled to starving
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tions/consequences depending on the proximity of the lesioned area.
Similar concepts may apply to other CNS diseases characterized by
damaged core regions such as AD (Aβ plaques), brain trauma and
epilepsy.5.6.2. Alzheimer's disease
AD is considered as one of the most prevalent forms of dementia in
humans. It is associated with several histopathological changes, includ-
ing senile plaque formation, neurofibrillary tangles (NFTs), neuroin-
flammation, altered synaptic connectivity and ultimately irreversible,
fatal neurodegeneration. NFTs are intraneuronal aggregates of paired
helical filaments of abnormally hyperphosphorylated Tau protein. Se-
nile plaques are extracellular aggregates mainly composed of Aβ
surrounded by dystrophic neurites, activatedmicroglia, and reactive as-
trocytes. ADmostly occurs as a late-onset, idiopathic or non-Mendelian
form, while only about 5% is familial. Familial AD has an early onset and
is inherited in an autosomal dominant manner due to mutations in the
amyloid pathway such as in APP or PS1/2, which are the catalytic sub-
unit of the γ-secretase complex that cleaves APP and releases Aβ.
The etiology of AD is poorly understood. The impairment of Ca2+ho-
meostasis is postulated to be an early event in the development of neu-
rodegenerative processes [440]. Some suggest that altered Ca2+
signaling may decrease synaptic strength and cell loss well before initi-
ating Aβ plaques while others place Aβ plaque formation as the start of
Ca2+ deregulation [440,441]. The accumulation of NFTs and Aβ plaques
may alter the Ca2+ household of the nervous tissue. For example, Tau
proteins alter the function of voltage-gated Ca2+ channels [442]where-
as PS form Ca2+ leak channels in the ER [443]. PS physically interact
with SERCA, IP3Rs and RyRs, facilitating ER Ca2+ uptake and release
[283,444,445]. FAD-linked mutations in PS have been found to either
abolish its Ca2+-leak properties [443] or to result in a gain-of-function
of IP3R channels [283]. The latter seems to activate a vicious circle, fur-
ther increasing the ratio of the toxic Aβ42 over Aβ40 levels. Interestingly,
Aβ42 can directly perturb intracellular Ca2+ homeostasis via IP3R-
dependent as well as -independentmechanisms [281]. Aβ also compro-
mises the ability of neurons to restore [Ca2+]i to baseline after a kainate
and NMDA-induced elevation, making them more vulnerable to
excitotoxicity [446]. In vivo evidence indicates that neurons in close
proximity to Aβ plaques are hyperactive and experience a Ca2+ over-
load [261]. Importantly, Aβ-induced Ca2+ overload has not only been
observed in neuronal cells but also in glial [262,447] and endothelial
cells [448,449]. Especially glial cells have recently caught the attention
of many leading AD research labs [450]. Atrophic and reactive astroglia
were detected in ADmousemodels [451], with reactive astrocytes being
directly associated with Aβ plaques [451] and NFTs [452]. Activated as-
trocytes and microglia furthermore modulate senile plaque formation,
either promoting [453] or inhibiting plaque growth [454]. Elevated
[Ca2+]i not only forms the basis for ER stress, glutathione depletion,
ROS production and astrogliosis, but may furthermore stimulate the
production and accumulation of Aβ peptide in astrocytes [262,263].
Mutations in PS have been shown to sensitize astrocytes to ATP and
glutamate [289], and Aβ alters metabotropic Ca2+ signaling via a
Ca2+-calcineurin-nuclear factor of activated T-cells (NFAT)-dependent
pathway. Aβ peptide activates calpain, which in turn cleaves and acti-
vates calcineurin, a vital component of NFAT-mediated gene expression.
Both calcineurin and calpain are well acknowledged as Ca2+ oscillation
sensors [455,456] and NFAT-dependent gene expression is thus tightly
linked to [Ca2+]i changes. Recent findings suggest that the Ca2+-cal-
cineurin-NFAT signaling axis is responsible for the overexpression of
metabotropic GluR5, IP3R1 and IP3R2 in astrocytes surrounding Aβ
plaques, resulting in altered Ca2+ homeostasis [290,457]. Importantly,
Aβ differentially affects astrocytemetabotropic Ca2+ signaling in differ-
ent brain regions whichmay account for the spatially distinct reactivity
of astrocytes in the progression of AD [290].Astrocyte ICWs have been shown to originate near Aβ plaques and
spread 200 μm radially [21]. Based on the observation that photo-
activation of caged IP3 in astrocytes in vivo does not provoke ICWs,
Crowe et al. [22] concluded that the spontaneous ICWs in AD mice do
not depend on the IP3-signaling axis. Increases in Cx43 and Cx30 ex-
pression have been observed in reactive astrocytes in the immediate vi-
cinity of the majority of Aβ plaques in AD mouse models [313]. This is
supported by an analysis performed in brain samples of AD patients,
which displayed an increase in Cx43 expression [458]. Aβ reduces GJIC
and induces HC opening in cultured astrocytes and brain slices [367,
402], however, these observations are not supported by experimental
results obtained from brain slices of APP-transgenic mice where GJ
dye coupling through astrocytic networks was maintained in slices
from different brain regions [459]. Interestingly, Aβ peptide has been
shown to lead to neuronal death via a cascade of HC activation, com-
posed of both Cxs and Panxs. First, activated microglia promote the re-
lease of glutamate and ATP through microglial Cx43 HCs and Panx1
channels and astrocytic Cx43 HCs, which subsequently induce neuronal
death by triggering Cx36 HC and Panx1 channel opening in neurons
[402].
5.6.3. Traumatic brain and spinal cord injury
Traumatic brain and spinal cord injury is often complicated by de-
layed progressively expanding cell damage and death to which Ca2+
ions and Cxs can contribute [460,461]. Several studies have demonstrat-
ed a neuroprotective role of Cx channel blockers/Cx silencing in trau-
matic CNS injury [42,319,387,404,462,463]. Not only neuronal Cx36
GJs play a role in the secondary neuronal death [463,464], but also
Cx43 channels can increase neuronal vulnerability to brain or spinal
cord injury [318,319,387]. Astrocytic Cx43 furthermore plays a role in
thedevelopment of chronic neuropathic pain following spinal cord inju-
ry [320]. Cx43 expression and phosphorylation are upregulated in re-
sponse to traumatic CNS injury [308,309,321,465–467] and the
phosphorylation of Cx43 is associated with autophagy in hippocampal
pyramidal neurons [467]. In addition, Cx29 and Cx32 expression are
de novo expressed in astrocytes and microglia localized in the injury
border zone [468].
Astrocyte ICWs were observed in vivo in the border/penumbral re-
gion after traumatic injury. These ICWs were dependent on purinergic
signaling, and affected the neuronal activity and survival in the border
zone [24]. ATP release via astrocytic Cx43 HCs is suggested to aggravate
the secondary injury [318]. Inositol polyphosphates are also released
from stretch-injured astrocytes in culture, suggesting that release of
IP3 from glial cells could affect neighboring neurons [469]. In accor-
dance, HCs have been put forth as IP3-releasing channels in the cochlea
where the sensory neuroepithelium expresses IP3R on the plasma
membrane [77]. It must be noted that IP3R expression has been identi-
fied in the plasma membrane of other cell types, but usually have the
IP3-sensing domain on the intracellular site [470]. It thus remains an
open question whether such signaling route can be activated from out-
side the cell.
5.6.4. Epilepsy
Excessive neuronal firing during epileptic seizures is associatedwith
marked alterations in the composition of the extracellular ions, most
notably an increase in K+ and a reduction of Ca2+ [471]. In accordance,
lowering of [Ca2+]e, for example by stimulating glutamatergic synaptic
transmission [254], has been shown to induce spontaneous epileptiform
activity in hippocampal slices [472]. The resulting drop in extracellular
Ca2+ stimulates CxHC opening that can further contribute to the trans-
location of Ca2+ ions to the intracellular compartment. Local or systemic
administration of IP3-linked metabotropic glutamate receptor agonists
can further contribute to excessive neuronal firing. Antagonists of
these receptors indeed have anti-convulsant properties. Additionally,
several anti-epileptic agents reduce the ability of astrocytes to transmit
Ca2+ signaling [26].
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crease in GJIC, and a surge in glutamate-induced Ca2+ oscillations and
ICWs [473],whichmight be the consequence of an elevation in extracel-
lular K+ concentration ([K+]e) [474]. The contribution of Cx channels to
ictogenesis is dual [4]. On the one hand, GJs may be anti-convulsive by
contributing to spatial buffering of K+ and glutamate. The combined ab-
lation of Cx43 and Cx30, which results in coupling-deficient astrocytes,
lowers the threshold for epileptiform activity and thus supports this no-
tion [52,57]. On the other hand, GJIC may be pro-convulsive by helping
to provide neurons with the energy supply required for neuronal burst-
ing, while ICWs propagated by GJs and CxHCsmay expand the hyperex-
cited Ca2+ state of the astrocyte network thus modulating remotely
located synapses [44,49]. In this respect, pharmacologic block of Cx
channels reduced seizure activity while a potentiation of cell–cell cou-
pling enhanced neuronal firing [52,388,475]. Interestingly, recent evi-
dence based on work with a peptide targeting the second extracellular
loop of Cx43 indicates that during an epileptiform insult, Cx43 HCopen-
ing is detrimental while GJIC is neuroprotective. By contrast, after the
seizure, GJIC exacerbates neuronal death [388].
Astrocytes themselves may be the origin of glutamate in epileptic
firing. Tian and co-workers [26] reported that paroxysomal depolariza-
tion shifts (PDSs, abnormally prolonged depolarizations with repetitive
spiking manisfesting as interictal discharges) can be initiated by the re-
lease of glutamate from extrasynaptic sources. The application of the K+
channel blocker 4-aminopyridine in the somatosensory cortex in vivo
triggered PDSs, and stimulated the appearance of astrocytic ICWs and
repetitive oscillatory Ca2+ increases. Astrocytic Ca2+ signaling invari-
ably preceded bursting activity and flash photolysis of caged Ca2+ in as-
trocytes was sufficient to trigger PDSs. Additional support for an
astrocytic origin is provided by the observation that intracellular dialy-
sis of IP3 into single astrocytes evokes glutamate release and epilepti-
form discharges in adjacent neurons in hippocampal slices [476]. Two
later studies demonstrated that glutamate release from astrocytes is
not necessary to evoke epileptiform activity in hippocampal slices
[477], but can evoke neuronal cell death in an in vivomodel of status ep-
ilepticus [25].
6. Conclusions
For decades, research has been focusing on the neuronal abnormal-
ities that accompany neurodegenerative disorders. However, at the
same time, it is becoming increasingly evident that astrocytes are also
important players in various CNS diseases. Reactive glial cells (mainly
astrocytes and microglia) have been identified in many disorders of
the CNS which boosted the interest in the potential role of these cells
in neuronal injury. Astrocytes form extensive networks that connect
neuronal synapses with the vasculature. This central position provides
astrocytes with several essential functions, i.e. sensing neuronal activity
aswell as participating in their signaling, integrating electrochemical in-
formation and exchanging this information with the vasculature. Here-
by, the canonical PLC/IP3/Ca2+ pathway is the language via which
astrocytes talk to each other as well as to neurons, microglia and vascu-
lar cells. The information processing within the glial network, as well as
the communication of this information to NGVU partner cells is sup-
ported by intercellular signaling via GJs or via paracrine communication,
possibly involving HCs. As such, it is no surprise that alterations of Cx
channel function will profoundly affect proper functioning of the
NGVU and will ultimately lead to cell dysfunction and cell death. An in-
creasing number of publications have reported the occurrence of glial
ICWs in vivo in various acute and chronic animal disease models such
as epilepsy, ischemia, brain trauma and AD. The exact functional impli-
cations of these glial-based ICWs are unclear. As suggested here, they
might provide the long-range transfer of information to evokeprocesses
such as reactive astrogliosis, microglial activation and neurodegenera-
tion. A balance between these processes likely determines the overall
influence exerted by astrocytes in these conditions, saver versus killer,and the level of destruction, protection and regeneration in neuropath-
ological conditions. These examples of pathological conditions suggest
further research to explore the terms and mechanisms leading to in-
creased appearance of ICWs, and to determine their contribution in
the pathogenesis and disease progression. Research on Cx-mediated
Ca2+ communication within the NGVU may ultimately shed light on
the development of targeted therapies for gliopathologies.
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